| NCT06981078 | A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD | RECRUITING | PHASE2 | 2025-07-02 | 2029-08 | 2029-04 |
| NCT06966479 | A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) | RECRUITING | PHASE2 | 2025-05-21 | 2027-09 | 2027-09 |
| NCT06196879 | A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-02-27 | 2026-06-11 | 2026-02-19 |
| NCT06164704 | A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps | COMPLETED | PHASE2 | 2023-12-18 | 2025-07-22 | 2025-07-07 |
| NCT05653479 | Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults | COMPLETED | PHASE1 | 2022-12-05 | 2023-05-13 | 2023-04-07 |
| NCT05448651 | Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics | COMPLETED | PHASE1 | 2022-07-08 | 2023-10-05 | 2023-08-15 |